Wenchun Zhou

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate

Michael R. McClung, Robert R. Recker, Paul D. Miller et al. · Bone · 2007 · 177 citations

Bone Disease, Bone Health, Osteoporosis +6

A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density

Kenneth G. Saag, R. Lindsay, Audrey Kriegman et al. · Bone · 2007 · 119 citations

Bone Disease, Bone Health, Weekly Oral Alendronate +8

Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study

Victor Shi, Michele Senni, Vikas Modgill et al. · International Journal of Cardiology · 2018 · 39 citations · Full text

Efficacy and Tolerability of Lumiracoxib 200 mg Once Daily for Treatment of Primary Dysmenorrhea: Results from Two Randomized Controlled Trials

Stephen Daniels, Xavier Gitton, Wenchun Zhou et al. · Journal of Women s Health · 2008 · 18 citations

Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)

Michael R. Loebinger, Eva Polverino, Francesco Blasi et al. · Pulmonary Pharmacology & Therapeutics · 2019 · 11 citations

Tobramycin Inhalation Powder, Respiratory Infection, Infectious Respiratory Disease +7